BRCA1 and BRCA2 Profile Test
53+ booked in last 3 daysBRCA1 and BRCA2 Test Overview
BRCA (Breast cancer) genes are tumor suppressor genes, which due to certain mutations or deletions may increase the risk for breast and ovarian cancers in some patients. BRCA 1 & 2 Profile using the NGS technology offers a strong approach for identifying and discovering novel genes linked to cancer susceptibility, as well as the opportunity to counsel patients and their families on screening, surveillance, and risk-reduction strategies.
Written by - Dr. Shibani R, Medical Writer, Medical Affairs
BRCA1 and BRCA2 Profile Test Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the BRCA1 and BRCA2 Profile Test with a clear pricing structure.
The BRCA1 and BRCA2 Profile Test Price in Virar is ₹ 16,000 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
The profile measures the mutations in the BRCA 1 & 2 genes based on the NGS technology.
- BRCA gene test is beneficial in predicting the risk of cancer diagnosis in people with susceptible genes
- Test may be done if the patient is diagnosed with breast or ovarian cancer (to establish cause of cancer) or if the patient has blood relatives who have had ovarian or breast cancer.
Those with family history of:
- Breast, Ovarian, fallopian tube, pancreatic, peritoneal or prostate cancers.
- Breast Cancer diagnosed before age of 45
- First degree relative with ovarian cancer
- Male breast cancer
- People belonging to certain ethnicity with positive family cancer history.
- Individuals with triple negative breast cancer below 60 years of age.
This test requires a blood sample. The sample is tested for mutations in the BRCA 1 & 2 genes.
Duly signed BRCA Proforma, BRCA1-2 Consent Form
Positive result may indicate mutations in the BRCA 1 and 2 genes, and based on that the variants may be classifies as:
Known Pathogenic, Likely pathogenic, VUS (Variants of unknown significance), Likely benign and Known benign
- BRCA 1 test
- BRCA 2 test
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.